Head and neck paragangliomas: Genetic spectrum and clinical variability in 79 consecutive patients

Endocrine-Related Cancer

Volumn 19, Issue 2, 2012, Pages 149-155

  Piccini, Valentina ^a   Rapizzi, Elena ^a   Bacca, Alessandra ^b   Di Trapani, Giuseppe ^c   Pulli, Raffaele ^a   Giachè, Valentino ^a   Zampetti, Benedetta ^a   Lucci Cordisco, Emanuela ^d   Canu, Letizia ^a   Corsini, Elisa ^a   Faggiano, Antongiulio ^e   Deiana, Luca ^f   Carrara, Davide ^b   Tantardini, Valeria ^b   Mariotti, Stefano ^f   Ambrosio, Maria Rosaria ^g   Zatelli, Maria Chiara ^g   Parenti, Gabriele ^h   Colao, Annamaria ^e   Pratesi, Carlo ^a   Bernini, Giampaolo ^b   Ercolino, Tonino ^h   Mannelli, Massimo ^a   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Othologic Group   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g UNIVERSITY OF FERRARA   (Italy)

^h CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MAX PROTEIN; MEMBRANE PROTEIN; METADRENALIN; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE A; SUCCINATE DEHYDROGENASE A F2; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE C; SUCCINATE DEHYDROGENASE D; TRANSMEMBRANE PROTEIN 127; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEAD AND NECK PARAGANGLIOMA; HEAD AND NECK TUMOR; HUMAN; MALE; PARAGANGLIOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CHI-SQUARE DISTRIBUTION; DNA, NEOPLASM; FEMALE; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARAGANGLIOMA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 84860893439     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0369     Document Type: Article

References (22)

1. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C & Maher ER 2001 Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics 69 49-54. (doi:10.1086/321282)
2. Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA et al. 2010 SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncology 11 366-372. (doi:10.1016/S1470-2045(10)70007-3)
3. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN et al. 2000 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287 848-851. (doi:10.1126/science.287.5454.848)
4. Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery WH III, Myers EN et al. 2002 Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. Journal of Medical Genetics 39 178-183. (doi:10.1136/jmg.39.3. 178)
5. Boedeker CC, Erlic Z, Richard S, Kontny U, Gimenez- Roqueplo AP, Cascon A, Robledo M, de Campos JM, van Nederveen FH, de Krijger RR et al. 2009 Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. Journal of Clinical Endocrinology and Metabolism 94 1938-1944. (doi:10.1210/jc.2009-0354)
6. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F et al. 2009 The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. Journal of Clinical Endocrinology and Metabolism 94 2817-2827. (doi:10.1210/jc.2008-2504)
7. Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Be'nit P, Tzagoloff A et al. 2010 SDHA is a tumor suppressor gene causing paraganglioma. Human Molecular Genetics 19 3011-3020. (doi:10.1093/hmg/ddq206)
8. Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F, Landa I, Leandro-García LJ, Letón R, Honrado E, Ramos-Medina R, Caronia D, Pita G et al. 2011 Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nature Genetics 43 663-667. (doi:10.1038/ng.861)
9. Ercolino T, Becherini L, Valeri A, Maiello M, Gaglianò MS, Parenti G, Ramazzotti M, Piscitelli E, Simi L, Pinzani P et al. 2008 Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations. Clinical Endocrinology 68 762-768. (doi:10. 1111/j.1365-2265.2007.03131.x)
10. Gaal J, van Nederveen FH, Erlic Z, Korpershoek E, Oldenburg R, Boedeker CC, Kontny U, Neumann HP, Dinjens WN & de Krijger RR 2009 Parasympathetic paragangliomas are part of the von Hippel-Lindau syndrome. Journal of Clinical Endocrinology and Metabolism 94 4367-4371. (doi:10.1210/jc.2009-1479)
11. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG et al. 2009 SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325 1139-1142. (doi:10.1126/science.1175689)
12. Hensen EF, Siemers MD, Jansen JC, Corssmit EPM, Romijn JA, Tops CMJ, Van der Mey AGL, Devilee P, Cornelisse CJ, Bayley JP et al. 2011 Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients. Clinical Endocrinology 75 650-655 (doi: 10.1111/j.1365- 2265.2011.04097.x). (doi:10.1111/j.1365-2265.2011.04097.x)
13. Lack EE 2004 Anatomy and physiology of peripheral arterial chemoreceptors. In Pathology of Adrenal and Extra-adrenal Paraganglia, 1st edn, pp 41-76. Ed, WB Saunders. Philadelphia, PA, USA: Saunders.
14. Lima J, Feijão T, Ferreira da Silva A, Pereira-Castro I, Fernandez-Ballester G, Máximo V, Herrero A, Serrano L, Sobrinho-Simões M & Garcia-Rostan G 2007 High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. Journal of Clinical Endocrinology and Metabolism 92 4853-4864. (doi:10.1210/jc.2007-0640)
15. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacché M, Mori L, Pignataro V, Bernini G, Giaché V, Bacca A et al. 2009 Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Journal of Clinical Endocrinology and Metabolism 94 1541-1547. (doi:10.1210/jc.2008-2419)
16. Mariman EC, van Beersum SE, Cremers CW, Struycken PM & Ropers HH 1995 Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Human Genetics 95 56-62. (doi:10.1007/BF00225075)
17. Neumann HP, Erlic Z, Boedeker CC, Rybicki LA, Robledo M, Hermsen M, Schiavi F, Falcioni M, Kwok P, Bauters C et al. 2009 Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fallout. Cancer Research 69 3650-3656. (doi:10.1158/0008-5472.CAN-08-4057)
18. Neumann HP, Sullivan M, Winter A, Malinoc A, Hoffmann MM, Boedeker CC, Bertz H, Walz MK, Moeller LC, Schmid KW et al. 2011 Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. Journal of Clinical Endocrinology and Metabolism 96 E1279-E1282. (doi:10.1210/jc.2011-0114)
19. Niemann S & Mueller U 2000 Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genetics 26 268-270. (doi:10.1038/81551)
20. Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ et al. 2010 Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Human Mutation 31 41-51. (doi:10.1002/humu.21136)
21. Simi L, Sestrini R, Ferruzzi P, Gallianò MS, Gensini F, Mascalchi M, Guerrini L, Pratesi C, Pinsani P, Nesi G et al. 2005 Phenotype variability of neural crest-derived tumors in six Italian families segregating the same founder SDHD mutation Q109X. Journal of Medical Genetics 42 e52.
22. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M & Jimenez C 2010 A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. Journal of Clinical Endocrinology and Metabolism 95 2023-2037. (doi:10.1210/jc.2009-2830)